Other Events ·
Kiora Pharmaceuticals, Inc. announced preclinical data demonstrating that its ion channel modulator platform…
KPRXKiora Pharmaceuticals Inc
Kiora Pharmaceuticals, Inc. announced preclinical data demonstrating that its ion channel modulator platform significantly suppressed seizure-associated electrophysiological activity in an ex vivo temporal lobe epilepsy model. The findings were presented at the Epilepsy Foundation Pipeline Conference in Leesburg, VA. Kiora Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapies for epilepsy and other neurological disorders.